Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Endotheliopathy is essential in COVID-19 associated coagulopathy

Alfred Ian Lee and George Goshua • 12 Jun 2020
EHA 2020
General

A notable feature of SARS-CoV-2 pathogenesis is COVID-19 associated coagulopathy (CAC), which is characterized by increased thrombotic and microvascular complications. George Goshua, MD, and Alfred Ian Lee, MD, PhD, Yale School of Medicine, New Haven, CT, measured markers of endothelial cell (EC) and platelet activation, PAI1 and coagulation factors in stable and critically ill patients hospitalized with COVID-19 to discern the pathophysiology of CAC. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from George Goshua

9:01
Distributional cost-effectiveness analysis of gene therapy vs SOC in patients with SCD in the US
George Goshua • 10 Dec 2022
9:35
Impact of implementing an RBC alloantibody exchange for SCD alloimmunisation
George Goshua • 12 Dec 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals